Companies / Callan JMB Inc

Callan JMB Inc

Nasdaq: CJMBCIK 2032545SPRING BRANCH, TX

Financials · FY2025

Revenue$5.72M
Net income$-7.97M
Total debt$0
Cash$1.42M
Diluted EPS$-1.82
Shares outstanding5.6M

Ownership

5.6M shares outstanding · as of May 14, 2026
14.2%Insiders
Ownership
Insiders14.20%802,000
10%+ / strategic4.35%245,682
Institutions8.19%462,527
Public float73.25%4,135,909

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insider% of sharesShares
Croyle David JChief Medical Officer · 10% owner
14.17%800,000
Dial GeraldDirector
0.04%2,000

Institutional holders 12

View all →

Activity

Mar 31, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Bard Associates, Inc.
13F manager
TrimCommon stock$-42.7K-34K
-12.22%
245,482
4.35% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
ExitCommon stock$-12.7K-11K
-100.00%
0
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon stock$12.3K+10K
+75.24%
22,969
0.41% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Bard Associates, Inc.Passive13G/A—245,682—
Bard Associates, Inc.Passive13G/A—239,266—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CJMB——131100109—